The Sanders-Brown Center on Aging at the University of Kentucky will hold its fourth annual Markesbery Symposium on Aging and Dementia on Friday and Saturday, Nov. 21-22.
The Markesbery Symposium is named in honor of the late Dr. William R. Markesbery, founder and long-time director of the UK Sanders-Brown Center on Aging and an internationally renowned expert on aging and dementia.
More than 5 million Americans have Alzheimer's disease (AD) today and millions more are affected by their role as family member, friend or caregiver to those with memory loss.
Two independent groups of researchers led by Sidney "Wally" Whiteheart, PhD, at the University of Kentucky, and Dr. Charles Lowenstein, at the University of Rochester, have published important studies exploring the role that a gene called STXBP5 plays in the development of cardiovascular disease.
According to Whiteheart, previous genome-wide association studies (GWAS) identified a gene called STXBP5 as a factor that regulates a protein called Von Willebrand factor (VWF).
VWF is an important contributor to normal blood clotting.
Did you know that you can help others by participating in research? Health-focused research affects every aspect of our lives, from the medications we take to the health of our environment. Researchers are working hard to identify new treatments and strategies to improve the health of our communities, but research needs healthy volunteers and volunteers with medical conditions in order to succeed.
The University of Kentucky Center for Health Services Research (CHSR), which serves as a connector, catalyst and creator at UK and UK HealthCare, announces the launch of its new website and seeks membership applicants for its efforts in applying research to optimize health care delivery. The CHSR is focused on creating, testing, and scaling next-generation health services research solutions to improve the efficiency and effectiveness of health delivery within Kentucky and beyond.
A team of investigators has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
Jason Meyer, a University of Kentucky M.D.-Ph.D.
The University of Kentucky's Center of Biomedical Research Excellence (COBRE) on the Molecular Basis of Human Disease was recently awarded a third phase of National Institutes of Health (NIH) funding for a program to develop its research community and center dedicated to human disease.
With this new $1.25 million annual grant, UK's COBRE will build upon achievements of a research development program that initially received NIH support in 2004.
Studies show that adults who received corrective surgery for the most common serious form of congenital heart disease as infants are susceptible to heart failure in adulthood.
Researchers at the University of Kentucky are using magnetic resonance imaging (MRI) technology to better understand the cause of heart failure in these patients, with the goal of eventually developing new therapies to reduce mortality. The team, led by University of Kentucky professor Dr.
Prior to medical school, members of the University of Kentucky College of Medicine Class of 2018 were chemists, Americorp volunteers, engineers, waiters, musicians, class leaders and archeologists. But the moment they were coated at the Singletary Center of the Arts on Aug. 1, the 136 students were all dedicated to becoming doctors.
Members of a diverse and highly accomplished incoming class of medical students were presented with their white coat, a universal symbol of compassion and humanism in medicine, during the White Coat Ceremony. Dr. Frederick C.
Prabhakara R Nagareddy, a scientist with the Saha Cardiovascular Research Institute at the University of Kentucky, has received a prestigious K99/R00 award from the National Institutes of Health.
Also known as the Pathway to Independence (PI) Award, this grant provides two years of mentored postdoctoral support followed by three years of independent support.
University of Kentucky Endowed Chair of Neuroscience Dr. Diane Snow was recently elected by her colleagues to serve as president-elect of the National Neurotrauma Society (NNS). With this appointment, Snow will hold the position of president in 2015-2016.
Since joining the NNS in 2003, Snow has championed women's contributions to neurotrauma research and mentorship opportunities for young members of the profession, including students, postdoctoral fellows and young professors.
A year ago, a crowd of hundreds gathered in Pavilion A of the University of Kentucky Chandler Hospital to celebrate a long-awaited special announcement – the unveiling of the UK Markey Cancer Center as the state's first and only National Cancer Institute-designated cancer center.
The designation was the culmination of years of tireless work by the faculty and staff of Markey and its supporting service lines and colleges – all guided by Director Dr.
Researchers from the Sanders-Brown Center on Aging at the University of Kentucky have been able to confirm anecdotal information on patients with both Alzheimer's disease (AD) and cerebrovascular disease (CVD) using mouse models in two different studies.
The findings of these two studies, which were recently published in Acta Neuropathologica and Alzheimer's Research & Therapy, have potentially significant implications for patients with both disorders.
Both papers studied CVD in Alzheimer's disease mouse models using different lifestyle factors.
Scientists at the University of Kentucky, led by nano-biotechnologist Peixuan Guo, have made some critical discoveries over the past year into the operation of biomotors, the molecular machines used by viruses and bacteria in the packaging of DNA.
Biomotors function similarly to mechanical motors but on a nano-scale. Last year, Guo's team reported the discovery of a new, third class of biomotor, unique in that it uses a "revolution without rotation" mechanism. Rotation is the turning of an object around its own axle, as the Earth does every 24 hours.
Not all learning experiences are created equally – and at the Learning Center at Linlee, an innovative partnership with the University of Kentucky College of Medicine allows young students to get rich, hands-on experience in the sciences and better their chances of succeeding in college and beyond.
As part of the Fayette County Public School System, The Learning Center (TLC) is an alternative school for at-risk students who are facing personal challenges that might impede their ability to learn. These include socioeconomic factors, and, perhaps surprisingly, intellectual giftedness.
UK HealthCare and Norton Healthcare are building upon their history of collaboration to expand research and educational collaborations between the two institutions, with the goal of improving health and health care for all Kentuckians.
Beginning July 1, educational and research initiatives between UK and Norton will be lead by Dr. Stephen Wyatt, who most recently served two successful terms as the founding dean of the University of Kentucky College of Public Health.
Congratulations are in order to Benjamin J. Fowler, PhD, who successfully defended his dissertation yesterday. Fowler has been studying under Dr. Jay Ambati in the Department of Ophthalmology. This milestone marks the conclusion of his graduate requirements of his PhD program. Fowler studies non-coding RNA biology in the context of a disease called age-related macular degeneration.
The MD-PhD curriculum at the University of Kentucky follows a traditional MSTP-style curriculum. Students usually graduate in 7 or 8 years; our average length of training is 7.3 years. Below is the typical time-line for training; in rare instances, individuals may tailor a different program.
The University of Kentucky’s MD/PhD program trains the best and brightest in the skills, intellectual tools and science of both clinical medicine and ground-breaking biomedical research. As one of only a handful of universities to have six healthcare colleges on the same campus, we offer a wide range of graduate training opportunities. What makes UK unique is the range of multidisciplinary research and the exchange between investigators from different academic disciplines in our research centers.
The University of Kentucky's Sanders-Brown Center on Aging is participating in a landmark multi-center clinical trial of an experimental drug that has the potential to prevent Alzheimer's disease (AD).
The A4 Study will recruit 1,000 participants ages 65-85 to test an amyloid antibody that may prevent memory loss caused by Alzheimer's disease. Amyloid is a protein normally produced in the brain that can build up in older people, forming plaque deposits in the brain.
New researchers in any field face challenges--limited research experience, competing demands for time, diminished levels of and increased competition for funding.
